Placebo-controlled phase II study of vitamin K3 cream for the treatment of cetuximab-induced rash
Crossref DOI link: https://doi.org/10.1007/s00520-017-3623-x
Published Online: 2017-02-15
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Eriksen, Jesper Grau
Kaalund, Inger
Clemmensen, Ole
Overgaard, Jens
Pfeiffer, Per
Funding for this research was provided by:
Fonden til Lægevidenskabens Fremme
Merck KGaA, Darmstadt, Germany
License valid from 2017-02-15